Get In Touch

Accelerating Glycomics Market During COVID-19 Outbreak

The increasing number of patients suffering from chronic diseases is anticipated to revive the growth of the global glycomics market. The market is expected to witness abundance of growth opportunities in the upcoming years. The increasing presence of pharmaceutical companies and research institutes to boost the drug discovery and development sector is driving the global glycomics market. Advancements in this field have played a major role in drug investigation during coronavirus pandemic. Technological advancements on biotechnology, investments on R&D activities to study gycans or polysaccharides, and increasing applications in disease diagnostics are creating revenue opportunities amid pandemic in the global market.

global glycomics market infographic

Request a sample to get extensive insights into the Glycomics Market

Surging Demand for Pharmaceutical Drugs and Treatments Globally

The global glycomics market is projected to cross US$ 3.1 Bn by 2031. The increasing demand for treatments for various chronic diseases is fueling the growth of the global glycomics market. Pharmaceutical companies are paving their ways in the global market to support R&D activities in glycans to generate more revenue opportunities. Increasing government expenditure on healthcare as well as in research & development activities in bioinformatics strengthen the scope and expansion of the market. Since cancer is one of the leading causes of death, there is an increasing focus of market contributors to support drug discovery and development activities in the field of oncology to create profitable opportunities.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Government Initiatives to Support and Invest in R&D Activities

Glycomics is the study of structure, biology, and function of saccharides or glycans, which can be found in all living organisms. The application of glycobiology in drug discovery & development, disease diagnostics, oncology, immunology, etc. has created tremendous growth opportunities for the players operating in the global market. The global glycomics market is expected to expand at a CAGR of 11.2% during the forecast period of 2021-2031. Pharmaceutical companies are increasing their output capacities to support the global glycomics market. Governments are taking steps ahead to support manufacturers in the pharmaceutical companies, and investing in R&D activities. The increasing healthcare expenditure by governments of developing countries to support research activities in the global market help fuel market growth.

Expansion of Academic & Research Institutes to Support Market Growth

Growth and advancement academic & research institutes to study glycomics, which has many applications in rapid development of drugs, vaccine development, and precision medicines, are factors expected to drive the global market during the forecast period. Increasing collaborations between research institutions and key market contributors to support research activities in biomedical and biochemistry are responsible for generating revenue streams. Expanding contact research organizations in pharmaceuticals to outsource R&D activities to stay ahead of the competition help grow manufactures operating in the global glycomics market. Increasing collaborate activities of market players and research institutes to study proteomics and glycomics to discover solutions on genetic diseases drives the global glycomics market.

global glycomics market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Glycomics Market

Analysts’ Viewpoint

There is a growing need of research and development activities in the field of glycan to study and understand the drug development lifecycle. Rising prevalence of chronic diseases such as cancer and diabetes, etc., technological advancements in pharmaceutical industry, and increasing research activities in the field of biotechnology to study the glycans are factors expected to create lucrative revenue opportunities for the global glycomics market players. However, there are still some challenges that need to be consider about the high costs of tools. Increasing investments on healthcare and presence of highly advanced research laboratories in the region are some of the factors responsible for the flourishing growth in North America.

Glycomics Market: Overview

  • This report analyzes the current scenario and future prospects of the global glycomics market. Growth of the global glycomics market is driven by increase in research activities on glycomics and rise in R&D investments in pharmaceutical and biotechnology companies.
  • The report provides an elaborate executive summary, including a snapshot of various segments of the global glycomics market. It also provides elaborate information and data analysis of the global glycomics market with regard to segments based on product type, application, end-user, and region.
  • The overview section of the report provides a detailed qualitative analysis of the drivers and restraints, and opportunities that affect the global glycomics market
  • Additionally, the report includes company profiles, which provide information about their business, product portfolios, and competition landscape in the glycomics market
  • The report on the global glycomics market offers market attractiveness analysis of the regions and segments
  • The last section of the report comprises quantitative and qualitative analysis on market share/position of key players operating in the global glycomics market. It analyzes the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global glycomics market.

Glycomics Market: Key Segments

  • In terms of product type, the global glycomics market has been classified into enzymes, instruments, kits, and reagents. The enzymes segment accounted for major share of the global glycomics market in 2020, and the trend is anticipated to continue during the forecast period.
  • Based on application, the global glycomics market has been categorized into diagnostics, drug discovery & development, oncology immunology, and others
  • In terms of end-user, the global glycomics market has been divided into academic research institutes, pharmaceutical & biotechnology companies, and contract research organizations
  • The market value and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segments has also been provided from 2021 to 2031, considering 2017 to 2019 as the historical years and 2020 as the base year.

Glycomics Market: Regional Outlook

  • The global glycomics market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The glycomics market report provides value and forecast for each region and country/sub-region from 2017 to 2031. The compound annual growth rates (CAGRs) for each of these regions and countries have also been provided for the forecast period from 2021 to 2031. The glycomics market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • Key players in the global glycomics market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global glycomics market report are
    • Agilent Technologies, Inc.
    • Asparia Glycomics
    • Bruker Corporation
    • Canadian Glycomics Network (GLYCONET)
    • Glyco Expression Technologies, Inc.
    • Glycodiag
    • Merck KGaA
    • New England Biolabs
    • RayBiotech, Inc.
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Vector Laboratories
    • Glyde Bio, Inc.

Glycomics Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 0.9 Bn

Market Forecast Value in 2031

US$ 3.1 Bn

Growth Rate (CAGR)

11.2%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Additionally, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, supply chain analysis, and parent industry overview.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Enzymes
      • Glycosidases
      • Glycosyltransferases
      • Neuraminidases
      • Sialyltransferases
      • Others
    • Instruments
      • Antibody Arrays
      • HPLC
      • Lectin Arrays
      • MALDI-TOF
      • Other Glycomics Instruments
    • Kits
      • Glycan Labeling Kits
      • Glycan Purification Kits
      • Glycan Release Kits
      • Others
    • Reagents
      • Glycoproteins
      • Monosaccharides
      • Oligosaccharides
      • Others
  • Application
    • Diagnostics
    • Drug Discovery & Development
    • Oncology
    • Immunology
    • Others
  • End User
    • Academic Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Japan
  • China
  • India
  • Australia
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Customization Scope

Available upon request

Pricing

Available upon request

Glycomics Market – Scope of Report

TMR’s report on the global glycomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the overall market revenue of the global glycomics market for the period 2017–2031, considering 2017 to 2019 as historical years, 2020 as the base year, and 2021 to 2031 as the forecast period. The report also provides the compound annual growth rate (CAGR) of the global glycomics market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, articles, journals, and relevant documents to understand the global glycomics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a top-down approach to study various phenomena in the global glycomics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global glycomics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global glycomics market. The next section of the global glycomics market report highlights the USPs, which include key mergers & acquisitions, technological advancements, major research institutes involved, and key developments in the global glycomics market.

The report delves into the competitive landscape of the global glycomics market. Key players operating in the global glycomics market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global glycomics market profiled in this report.

Key Questions Answered in Glycomics Market Report

  • What are the major drivers, restraints, and opportunities in the global market?
  • What will be the revenue share projections of key segments of the global glycomics market during the forecast period?
  • Which segment is likely to lead the global glycomics market in terms of revenue by 2031?
  • How mergers & acquisitions among players are widening the scope of the global glycomics market?
  • Which are the leading companies in the global glycomics market?

Glycomics Market – Research Objectives and Research Approach

The comprehensive report on the global glycomics market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of research in the glycomics market. It is followed by market introduction, market dynamics, and an overview of the global glycomics market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global glycomics market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the glycomics market. The next section of the glycomics market report highlights the USPs, which include technology snapshot, process overview, prominent software tools, key industry developments, regulatory scenario, and reimbursement scenario in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global glycomics market in terms of product type, application, end-user, and region. Key segments under each criteria have been studied at length, and the market share of each of them at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the glycomics market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Glycomics Market – Segmentation

Product Type
  • Enzymes
    • Glycosidases
    • Glycosyltransferases
    • Neuraminidases
    • Sialyltransferases
    • Others
  • Instruments
    • Antibody Arrays
    • HPLC
    • Lectin Arrays
    • MALDI-TOF
    • Other Glycomics Instruments
  • Kits
    • Glycan Labeling Kits
    • Glycan Purification Kits
    • Glycan Release Kits
    • Others
  • Reagents
    • Glycoproteins
    • Monosaccharides
    • Oligosaccharides
    • Others
Application
  • Diagnostics
  • Drug Discovery & Development
  • Oncology
  • Immunology
  • Others
End-user
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Glycomics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Glycomics Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)

    5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    5.3. Technological Advancements

6. Global Glycomics Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2017–2031

        6.3.1. Enzymes

            6.3.1.1. Glycosidases

            6.3.1.2. Glycosyltransferases

            6.3.1.3. Neuraminidases

            6.3.1.4. Sialyltransferases

            6.3.1.5. Others

        6.3.2. Instruments

            6.3.2.1. Antibody Arrays

            6.3.2.2. HPLC

            6.3.2.3. Lectin Arrays

            6.3.2.4. MALDI-TOF

            6.3.2.5. Other Glycomics Instruments

        6.3.3. Kits

            6.3.3.1. Glycan Labeling Kits

            6.3.3.2. Glycan Purification Kits

            6.3.3.3. Glycan Release Kits

            6.3.3.4. Others

        6.3.4. Reagents

            6.3.4.1. Glycoproteins

            6.3.4.2. Monosaccharides

            6.3.4.3. Oligosaccharides

            6.3.4.4. Others

    6.4. Market Attractiveness Analysis, by Product Type

7. Global Glycomics Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Diagnostics

        7.3.2. Drug Discovery & Development

        7.3.3. Oncology

        7.3.4. Immunology

        7.3.5. Others

    7.4. Market Attractiveness Analysis, by Application

8. Global Glycomics Market Analysis and Forecast End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Academic Research Institute

        8.3.2. Pharmaceutical & Biotechnology Companies

        8.3.3. Contract Research Organizations

    8.4. Market Attractiveness Analysis, by End-user

9. Global Glycomics Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Market Attractiveness Analysis, by Country/Region

10. North America Glycomics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product Type, 2017–2031

        10.2.1. Enzymes

            10.2.1.1. Glycosidases

            10.2.1.2. Glycosyltransferases

            10.2.1.3. Neuraminidases

            10.2.1.4. Sialyltransferases

            10.2.1.5. Others

        10.2.2. Instruments

            10.2.2.1. Antibody Arrays

            10.2.2.2. HPLC

            10.2.2.3. Lectin Arrays

            10.2.2.4. MALDI-TOF

            10.2.2.5. Other Glycomics Instruments

        10.2.3. Kits

            10.2.3.1. Glycan Labeling Kits

            10.2.3.2. Glycan Purification Kits

            10.2.3.3. Glycan Release Kits

            10.2.3.4. Others

        10.2.4. Reagents

            10.2.4.1. Glycoproteins

            10.2.4.2. Monosaccharides

            10.2.4.3. Oligosaccharides

            10.2.4.4. Others

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Diagnostics

        10.3.2. Drug Discovery & Development

        10.3.3. Oncology

        10.3.4. Immunology

        10.3.5. Others

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Academic Research Institute

        10.4.2. Pharmaceutical & Biotechnology Companies

        10.4.3. Contract Research Organizations

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product Type

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Glycomics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017–2031

        11.2.1. Enzymes

            11.2.1.1. Glycosidases

            11.2.1.2. Glycosyltransferases

            11.2.1.3. Neuraminidases

            11.2.1.4. Sialyltransferases

            11.2.1.5. Others

        11.2.2. Instruments

            11.2.2.1. Antibody Arrays

            11.2.2.2. HPLC

            11.2.2.3. Lectin Arrays

            11.2.2.4. MALDI-TOF

            11.2.2.5. Other Glycomics Instruments

        11.2.3. Kits

            11.2.3.1. Glycan Labeling Kits

            11.2.3.2. Glycan Purification Kits

            11.2.3.3. Glycan Release Kits

            11.2.3.4. Others

        11.2.4. Reagents

            11.2.4.1. Glycoproteins

            11.2.4.2. Monosaccharides

            11.2.4.3. Oligosaccharides

            11.2.4.4. Others

    11.3. Market Value Forecast Application, 2017–2031

        11.3.1. Diagnostics

        11.3.2. Drug Discovery & Development

        11.3.3. Oncology

        11.3.4. Immunology

        11.3.5. Others

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Academic Research Institute

        11.4.2. Pharmaceutical & Biotechnology Companies

        11.4.3. Contract Research Organizations

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. U.K.

        11.5.2. Germany

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product Type

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Glycomics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2017–2031

        12.2.1. Enzymes

            12.2.1.1. Glycosidases

            12.2.1.2. Glycosyltransferases

            12.2.1.3. Neuraminidases

            12.2.1.4. Sialyltransferases

            12.2.1.5. Others

        12.2.2. Instruments

            12.2.2.1. Antibody Arrays

            12.2.2.2. HPLC

            12.2.2.3. Lectin Arrays

            12.2.2.4. MALDI-TOF

            12.2.2.5. Other Glycomics Instruments

        12.2.3. Kits

            12.2.3.1. Glycan Labeling Kits

            12.2.3.2. Glycan Purification Kits

            12.2.3.3. Glycan Release Kits

            12.2.3.4. Others

        12.2.4. Reagents

            12.2.4.1. Glycoproteins

            12.2.4.2. Monosaccharides

            12.2.4.3. Oligosaccharides

            12.2.4.4. Others

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Diagnostics

        12.3.2. Drug Discovery & Development

        12.3.3. Oncology

        12.3.4. Immunology

        12.3.5. Others

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Academic Research Institute

        12.4.2. Pharmaceutical & Biotechnology Companies

        12.4.3. Contract Research Organizations

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. India

        12.5.3. Japan

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product Type

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Glycomics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2017–2031

        13.2.1. Enzymes

            13.2.1.1. Glycosidases

            13.2.1.2. Glycosyltransferases

            13.2.1.3. Neuraminidases

            13.2.1.4. Sialyltransferases

            13.2.1.5. Others

        13.2.2. Instruments

            13.2.2.1. Antibody Arrays

            13.2.2.2. HPLC

            13.2.2.3. Lectin Arrays

            13.2.2.4. MALDI-TOF

            13.2.2.5. Other Glycomics Instruments

        13.2.3. Kits

            13.2.3.1. Glycan Labeling Kits

            13.2.3.2. Glycan Purification Kits

            13.2.3.3. Glycan Release Kits

            13.2.3.4. Others

        13.2.4. Reagents

            13.2.4.1. Glycoproteins

            13.2.4.2. Monosaccharides

            13.2.4.3. Oligosaccharides

            13.2.4.4. Others

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Diagnostics

        13.3.2. Drug Discovery & Development

        13.3.3. Oncology

        13.3.4. Immunology

        13.3.5. Others

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Academic Research Institute

        13.4.2. Pharmaceutical & Biotechnology Companies

        13.4.3. Contract Research Organizations

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product Type

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Glycomics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product Type, 2017–2031

        14.2.1. Enzymes

            14.2.1.1. Glycosidases

            14.2.1.2. Glycosyltransferases

            14.2.1.3. Neuraminidases

            14.2.1.4. Sialyltransferases

            14.2.1.5. Others

        14.2.2. Instruments

            14.2.2.1. Antibody Arrays

            14.2.2.2. HPLC

            14.2.2.3. Lectin Arrays

            14.2.2.4. MALDI-TOF

            14.2.2.5. Other Glycomics Instruments

        14.2.3. Kits

            14.2.3.1. Glycan Labeling Kits

            14.2.3.2. Glycan Purification Kits

            14.2.3.3. Glycan Release Kits

            14.2.3.4. Others

        14.2.4. Reagents

            14.2.4.1. Glycoproteins

            14.2.4.2. Monosaccharides

            14.2.4.3. Oligosaccharides

            14.2.4.4. Others

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Diagnostics

        14.3.2. Drug Discovery & Development

        14.3.3. Oncology

        14.3.4. Immunology

        14.3.5. Others

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Academic Research Institute

        14.4.2. Pharmaceutical & Biotechnology Companies

        14.4.3. Contract Research Organizations

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product Type

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix

    15.2. Market Share Analysis, by Company, 2020

    15.3. Competitive Business Strategies

    15.4. Company Profiles

        15.4.1. Agilent Technologies, Inc.

            15.4.1.1. Company Description

            15.4.1.2. Business Overview

            15.4.1.3. Financial Overview

            15.4.1.4. SWOT Analysis

        15.4.2. Asparia Glycomics

            15.4.2.1. Company Description

            15.4.2.2. SWOT Analysis

        15.4.3. Bruker Corporation

            15.4.3.1. Company Description

            15.4.3.2. Business Overview

            15.4.3.3. Financial Overview

            15.4.3.4. SWOT Analysis

        15.4.4. Canadian Glycomics Network (GLYCONET)

            15.4.4.1. Company Description

            15.4.4.2. Business Overview

            15.4.4.3. SWOT Analysis

        15.4.5. Glyco Expression Technologies, Inc.

            15.4.5.1. Company Description

            15.4.5.2. SWOT Analysis

        15.4.6. Glycodiag

            15.4.6.1. Company Description

            15.4.6.2. Business Overview

            15.4.6.3. SWOT Analysis

        15.4.7. Merck KGaA

            15.4.7.1. Company Description

            15.4.7.2. Business Overview

            15.4.7.3. Financial Overview

            15.4.7.4. SWOT Analysis

        15.4.8. New England Biolabs

            15.4.8.1. Company Description

            15.4.8.2. Business Overview

            15.4.8.3. SWOT Analysis

        15.4.9. RayBiotech, Inc.

            15.4.9.1. Company Description

            15.4.9.2. SWOT Analysis

        15.4.10. Shimadzu Corporation

            15.4.10.1. Company Description

            15.4.10.2. Business Overview

            15.4.10.3. Financial Overview

            15.4.10.4. SWOT Analysis

        15.4.11. Thermo Fisher Scientific, Inc.

            15.4.11.1. Company Description

            15.4.11.2. Business Overview

            15.4.11.3. Financial Overview

            15.4.11.4. SWOT Analysis

        15.4.12. Vector Laboratories

            15.4.12.1. Company Description

            15.4.12.2. Business Overview

            15.4.12.3. SWOT Analysis

        15.4.13. Glyde Bio, Inc.

            15.4.13.1. Company Description

            15.4.13.2. SWOT Analysis

List of Tables

Table 01: Global Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 03: Global Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 04: Global Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 05: Global Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 06: Global Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 07: Global Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 08: Global Glycomics Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 09: North America Glycomics Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031

Table 10: North America Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 11: North America Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 12: North America Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 13: North America Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 14: North America Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 15: North America Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 16: North America Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 17: Europe Glycomics Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Europe Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 19: Europe Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 20: Europe Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 21: Europe Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 22: Europe Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 23: Europe Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 24: Europe Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 25: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 27: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 28: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 29: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 30: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 31: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 32: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 33: Latin America Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 34: Latin America Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 35: Latin America Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 36: Latin America Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 37: Latin America Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 38: Latin America Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 39: Latin America Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 40: Latin America Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 41: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 42: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 43: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

Table 44: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

Table 45: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

Table 46: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

Table 47: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 48: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Glycomics Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Glycomics Market Value Share, by Product Type, 2020

Figure 03: Global Glycomics Market Value Share, by Application, 2020

Figure 04: Global Glycomics Market Value Share, by End-user, 2020

Figure 05: Global Glycomics Market Value Share, by Region, 2020

Figure 06: Global Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 07: Global Glycomics Market Attractiveness Analysis, by Product Type , 2021–2031

Figure 08: Global Glycomics Market Revenue (US$ Mn), by Enzymes, 2017–2031

Figure 09: Global Glycomics Market Revenue (US$ Mn), by Instruments, 2017–2031

Figure 10: Global Glycomics Market Revenue (US$ Mn), by Kits, 2017–2031

Figure 11: Global Glycomics Market Revenue (US$ Mn), by Reagents, 2017–2031

Figure 12: Global Glycomics Market Value Share Analysis, by Application, 2020 and 2031

Figure 13: Global Glycomics Market Attractiveness Analysis, by Application, 2021–2031

Figure 14: Global Glycomics Market Revenue (US$ Mn), by Diagnostics, 2017–2031

Figure 15: Global Glycomics Market Revenue (US$ Mn), by Drug Discovery & Development, 2017–2031

Figure 16: Global Glycomics Market Revenue (US$ Mn), by Oncology, 2017–2031

Figure 17: Global Glycomics Market Revenue (US$ Mn), by Immunology, 2017–2031

Figure 18: Global Glycomics Market Value (US$ Mn), by Others, 2017–2031

Figure 19: Global Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

Figure 20: Global Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 21: Global Glycomics Market Revenue (US$ Mn), by Academic Research Institutes, 2017–2031

Figure 22: Global Glycomics Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031

Figure 23: Global Glycomics Market Value (US$ Mn), by Contract Research Organizations, 2017–2031

Figure 24: Global Glycomics Market Value Share Analysis, by Region, 2020 and 2031

Figure 25: Global Glycomics Market Analysis, by Region

Figure 26: North America Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 27: North America Glycomics Market Analysis Value Share Analysis, by Country, 2020 and 2031

Figure 28: North America Glycomics Market Analysis Attractiveness Analysis, by Country 2021–2031

Figure 29: North America Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 30: North America Glycomics Market Attractiveness Analysis, by Product Type , 2021–2031

Figure 31: North America Glycomics Market Value Share Analysis, by Application, 2020 and 2031

Figure 32: North America Glycomics Market Attractiveness Analysis, by Application, 2021–2031

Figure 33: North America Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

Figure 34: North America Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 35: Europe Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 36: Europe Glycomics Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 37: Europe Glycomics Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 38: Europe Glycomics Market Value Share Analysis, by Product Type,

Figure 39: Europe Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 40: Europe Glycomics Market Value Share Analysis, by Application, 2020 and 2031

Figure 41: Europe Glycomics Market Attractiveness Analysis, by Application, 2021–2031

Figure 42: Europe Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

Figure 43: Europe Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 44: Asia Pacific Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 45: Asia Pacific Glycomics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 46: Asia Pacific Glycomics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 47: Asia Pacific Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 48: Asia Pacific Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 49: Asia Pacific Glycomics Market Value Share Analysis, by Application, 2020 and 2031

Figure 50: Asia Pacific Glycomics Market Attractiveness Analysis, by Application, 2021–2031

Figure 51: Asia Pacific Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

Figure 52: Asia Pacific Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 53: Latin America Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 54: Latin America Glycomics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 55: Latin America Glycomics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 56: Latin America Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 57: Latin America Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 58: Latin America Glycomics Market Value Share Analysis, by Application, 2020 and 2031

Figure 59: Latin America Glycomics Market Attractiveness Analysis, by Application, 2021–2031

Figure 60: Latin America Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

Figure 61: Latin America Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

Figure 62: Middle East & Africa Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031

Figure 63: Middle East & Africa Glycomics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 64: Middle East & Africa Glycomics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 65: Middle East & Africa Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 66: Middle East & Africa Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 67: Middle East & Africa Glycomics Market Value Share Analysis, by Application, 2020 and 2031

Figure 68: Middle East & Africa Glycomics Market Attractiveness Analysis, by Application, 2021–2031

Figure 69: Middle East & Africa Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

Figure 70: Middle East & Africa Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Glycomics Market